Tirzepatide: dosage, side effects, and semaglutide compared
Tirzepatide is the active ingredient in Zepbound and Mounjaro. Here’s the dosage schedule, the side effects to expect, and how it stacks up against semaglutide. When you’re ready, a licensed Roen provider can evaluate you online.
- A once-weekly injection that acts on two hormone pathways, GIP and GLP-1
- Brand-name tirzepatide as low as $25/mo when your insurance covers it*
- Compounded tirzepatide for $329/mo, or $216/mo on a quarterly plan
- No appointment needed. Evaluations are handled by message
See important safety information for tirzepatide, including a boxed warning.
What is tirzepatide?
Tirzepatide is a once-weekly injectable medication developed by Eli Lilly. It’s the first drug to activate two gut-hormone receptors at once, GIP and GLP-1. Together they slow how quickly your stomach empties, reduce appetite, and help your body manage blood sugar.
Lilly sells it under two brand names. Mounjaro was approved in May 2022 for type 2 diabetes. Zepbound was approved in November 2023 for chronic weight management and in December 2024 for obstructive sleep apnea in adults with obesity.2,3 There is no FDA-approved generic.
Zepbound, Mounjaro, or compounded: what’s the difference?
All three contain tirzepatide. What separates them is who makes them, what they’re approved for, and who pays.
Zepbound
- FDA-approved for weight management and for sleep apnea in adults with obesity.
- The brand insurers consider when the goal is weight loss.
Mounjaro
- FDA-approved for type 2 diabetes.
- Usually covered only with a diabetes diagnosis.
Compounded tirzepatide
- Prepared by a compounding pharmacy for an individual prescription.
- Not FDA-approved. The FDA has not reviewed it for safety, effectiveness, or quality.
- An option a Roen provider may prescribe when insurance won’t cover a brand.
What is the usual tirzepatide dosage?
Tirzepatide is injected once a week. The dosage starts low and rises in steps so your body can adjust.2
- Starting dosage: 2.5 mg a week for four weeks.
- Increases: to 5 mg, then 2.5 mg at a time, with at least four weeks on each dose.
- Maintenance dosage for weight management: 5 mg, 10 mg, or 15 mg a week.
- Maximum dosage: 15 mg a week.
See the full tirzepatide dosage schedule.
*Requires commercial insurance that covers the prescribed brand and enrollment in Eli Lilly’s savings card for that brand. Savings limits apply and government-insured patients are not eligible. See cost details. †$216/mo applies to a quarterly plan; $329/mo billed monthly. Compounded medications are not FDA-approved. Roen membership ($39 first month, then $135/mo) is separate from medication.
Safety summary: Tirzepatide can cause serious side effects, including possible thyroid tumors. Do not use it if you or a family member has had medullary thyroid carcinoma (MTC) or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Read more safety information.
In a head-to-head trial, people on tirzepatide lost about 20% of their body weight
The 72-week SURMOUNT-5 trial compared tirzepatide with semaglutide in adults with obesity who didn’t have diabetes. Average weight loss was 20.2% on tirzepatide and 13.7% on semaglutide.1 In an earlier placebo-controlled trial, tirzepatide averaged 15.0% to 20.9% depending on dose, compared with 3.1% on placebo.7
at the 20.2% average 51lbs
Semaglutide group in the same trial: about 34 lbs
An illustration based on trial averages for FDA-approved tirzepatide, not a prediction. Participants also received diet and exercise counseling. Compounded tirzepatide was not studied in these trials.
The two brand names for tirzepatide
Zepbound and Mounjaro are the same molecule in the same doses. The label on the box decides what insurance will pay for.
| Zepbound®For weight management | Mounjaro®For type 2 diabetes | |
|---|---|---|
| Active ingredient | Tirzepatide | Tirzepatide |
| FDA-approved for | Chronic weight management, and obstructive sleep apnea in adults with obesity | Type 2 diabetes |
| Strengths | 2.5 mg to 15 mg, once a week | 2.5 mg to 15 mg, once a week |
| Insurance usually covers it when | Your plan includes weight-management drugs and you meet its criteria | You have a type 2 diabetes diagnosis |
| Lilly savings card | As low as $25/mo with covered commercial insurance | As low as $25/mo with covered commercial insurance, for on-label use |
| Self-pay through LillyDirect | $299 to $449/mo for the KwikPen or vial | From $499/mo for the single-dose pen |
| If neither is covered | A Roen provider can prescribe compounded tirzepatide when appropriate: $329/mo, or $216/mo on a quarterly plan. | |
How to get tirzepatide through Roen
The process is the same whichever form of tirzepatide you end up with, and it all happens online.
1. Join and complete your intake
Start your membership for $39 and answer questions about your health history, current medications, and goals. It takes a few minutes and you can do it from your phone.
2. A provider evaluates you
A licensed Roen clinician reviews your intake and decides whether tirzepatide is safe and appropriate for you. The review is asynchronous, so there’s no visit to schedule. If they have questions, they’ll message you.
3. We check both brands against your plan
Upload your insurance card. We’ll look at whether your plan covers Zepbound or Mounjaro, since plans often treat them differently. With coverage and Lilly’s savings card, either can cost as little as $25 a month.
4. Your prescription goes out
Covered: your brand-name prescription is filled through a partner pharmacy. Not covered: your provider can prescribe compounded tirzepatide, shipped to your door for $329 a month, or $216 a month on a quarterly plan.
5. Step up your dose with support
Tirzepatide starts at 2.5 mg and increases gradually. Your care team is a message away if side effects appear or you’re unsure about a dose change. Your provider adjusts the plan as you go.

One membership, every form of tirzepatide
- Evaluation by a licensed provider, with a prescription when appropriate
- Insurance checks for both Zepbound and Mounjaro
- Asynchronous care, with visits included on request
- Dose increases managed by your provider
- Ongoing help with side effects
- Access to Zepbound, Mounjaro, and compounded tirzepatide
Medication is not included in the membership price and is billed separately.
Get StartedTirzepatide side effects: what’s common and what’s serious
The most common tirzepatide side effects are nausea, diarrhea, vomiting, constipation, stomach pain, and indigestion. They’re tied to dose changes more than anything else, and rates ran higher in Zepbound’s weight-management trials than in Mounjaro’s diabetes trials.
| Common side effect | Zepbound trials | Mounjaro trials |
|---|---|---|
| Nausea | 25–29% | 12–18% |
| Diarrhea | 19–23% | 12–17% |
| Constipation | 11–17% | 6–7% |
| Vomiting | 8–13% | 5–9% |
| Stomach (abdominal) pain | 9–10% | 5–6% |
| Indigestion | 9–10% | 5–8% |
| Injection-site reactions | 6–8% | about 3% |
Approximate share of adults reporting each effect on tirzepatide in placebo-controlled trials, across the 5 mg, 10 mg, and 15 mg doses.2,3 These figures come from studies of the FDA-approved products.
How long do tirzepatide side effects last?
In the trials, most nausea, vomiting, and diarrhea happened while the dose was still being increased, and it eased over time. In Zepbound’s weight-management trials, 4.8% to 6.7% of people stopped treatment because of side effects, compared with 3.4% on placebo.2
Other tirzepatide side effects
In Zepbound’s trials, reactions at the injection site affected 6% to 8% of people, fatigue 5% to 7%, and hair loss 4% to 5%. On placebo, each was reported by 1% to 3%. Hair loss was linked to the weight loss itself and was more common in women.2
How to make tirzepatide easier to tolerate
- Have smaller meals, and stop eating once you feel full.
- Cut back on fatty and fried food, particularly the day you inject.
- Stay hydrated. Losing fluid through vomiting or diarrhea can strain your kidneys.
- Change your injection site each week: abdomen, thigh, or back of the upper arm.
- Speak up about symptoms that persist. Your provider can delay the next increase.
Serious side effects: get help right away
- Pancreatitis: severe pain in your stomach area that doesn’t let up and may spread to your back, with or without vomiting.
- Low blood sugar, especially alongside insulin or a sulfonylurea: shakiness, sweating, dizziness, confusion, fast heartbeat.
- Serious allergic reaction: swelling of the face, lips, tongue, or throat; trouble breathing or swallowing; severe rash.
- Kidney problems brought on by dehydration from vomiting or diarrhea.
- Gallbladder problems: pain in the upper stomach, fever, yellowing of the skin or eyes, pale stools.
- Vision changes, particularly if you have type 2 diabetes.
- A lump or swelling in your neck, hoarseness, or trouble swallowing. See the boxed warning.
Side effects track closely with dose changes. See the tirzepatide dosage schedule below, and our guide to tirzepatide side effects.
Tirzepatide dosage: the weekly schedule from 2.5 mg to 15 mg
Tirzepatide is taken once a week. The dosage starts at 2.5 mg and goes up in 2.5 mg steps, with at least four weeks on each dose, until you and your provider find the one that works.
| Weekly dosage | Earliest timing | Role |
|---|---|---|
| 2.5 mg | Weeks 1–4 | Starting dosage. For Zepbound it’s only for getting started, not for long-term use. |
| 5 mg | Week 5 | First increase, and the lowest maintenance dosage for weight management. |
| 7.5 mg | Week 9 | A step between maintenance dosages. |
| 10 mg | Week 13 | Maintenance dosage. |
| 12.5 mg | Week 17 | A step between maintenance dosages. |
| 15 mg | Week 21 | Maintenance dosage, and the maximum. |
Based on the prescribing information for Zepbound and Mounjaro.2,3 The weeks shown are the fastest schedule the labels allow. Your provider may keep you at a dosage longer, or settle on a lower one, depending on how you respond and how you feel.
Tirzepatide dosage isn’t based on body weight, and it doesn’t change for kidney or liver problems.2 For more detail, see our tirzepatide dosing schedule and tirzepatide dosage for weight loss guides. If your prescription comes in a vial, our tirzepatide dosing in units chart converts each dose from milligrams to syringe units.
Tirzepatide dosage by condition
- Weight management (Zepbound): maintenance dosage of 5 mg, 10 mg, or 15 mg a week.
- Obstructive sleep apnea (Zepbound): 10 mg or 15 mg a week.
- Type 2 diabetes (Mounjaro): starts at 2.5 mg and is raised only as needed for blood sugar, up to 15 mg a week in adults.
- Compounded tirzepatide: your provider sets the dosage. Follow your prescription and pharmacy label exactly.
Missed doses and changing your day
- Take a missed dose as soon as you can within 4 days (96 hours).
- After 4 days, skip it and take your next dose on your regular day.
- You can change your injection day if your last dose was at least 3 days (72 hours) earlier.
- Never take two doses to catch up.
Taking your dose
- Same day each week, at any time of day, with or without food.
- Inject under the skin of your abdomen, thigh, or the back of your upper arm, and rotate the spot.
- Brand-name pens deliver one fixed dose. With a vial, check the amount on your label each time you draw up a dose, especially after a dosage change.
- If side effects are hard to live with, your provider can hold your dosage or lower it.
Semaglutide vs tirzepatide: how the two compare
Both are once-weekly injections for weight management and type 2 diabetes. Tirzepatide acts on two hormone pathways and semaglutide on one, and in the only large head-to-head trial, tirzepatide led to more weight loss.1
| TirzepatideZepbound®, Mounjaro® | SemaglutideWegovy®, Ozempic® | |
|---|---|---|
| How it works | Activates two hormone receptors, GIP and GLP-1 | Activates one hormone receptor, GLP-1 |
| Made by | Eli Lilly | Novo Nordisk |
| FDA-approved for | Weight management and obstructive sleep apnea (Zepbound). Type 2 diabetes (Mounjaro) | Weight management and cardiovascular risk reduction (Wegovy). Type 2 diabetes (Ozempic) |
| Weight loss, head-to-head | 20.2% at 72 weeks1 | 13.7% at 72 weeks1 |
| Weight loss vs. placebo, separate trials | 15.0% to 20.9% at 72 weeks7 | 14.9% at 68 weeks9 |
| Weekly dosage | 2.5 mg up to 15 mg | 0.25 mg up to 2.4 mg (Wegovy) |
| Nausea in weight-management trials | 25% to 29%2 | 44%10 |
| Forms | Weekly injection | Weekly injection, or a daily pill |
| Compounded, through Roen | $329/mo, or $216/mo on a quarterly plan | $199/mo, or $106/mo on a 3-month supply |
| Brand-name, insurance covers it | As low as $25/mo for either, with the manufacturer’s savings offer. | |
Side effect rates come from each drug’s own placebo-controlled trials, so they aren’t a direct comparison. Compounded medications are not FDA-approved.
Looking at it from the other side? See our semaglutide page for semaglutide’s side effects, pricing, and dosing.
What the head-to-head trial found
- SURMOUNT-5 followed 751 adults with obesity, none with diabetes, for 72 weeks.
- Average weight loss was 20.2% on tirzepatide and 13.7% on semaglutide.
- Waistlines shrank by about 18 cm on tirzepatide and 13 cm on semaglutide.
- Digestive side effects were the most common in both groups, and most were mild to moderate.
- The trial was funded by Eli Lilly, which makes tirzepatide.
Source: SURMOUNT-5.1
When tirzepatide may fit better
- The amount of weight loss is your main priority.
- You have obstructive sleep apnea along with obesity. Zepbound is approved for it.
- Your insurance covers Zepbound or Mounjaro.
When semaglutide may fit better
- You have heart disease. Wegovy is approved to lower cardiovascular risk in adults with heart disease and obesity or overweight.
- You’d rather take a daily pill than a weekly injection.
- Your insurance covers Wegovy or Ozempic, or the lower compounded price matters to you.
Tirzepatide cost: brand, self-pay, and compounded prices
What tirzepatide costs depends on which form you’re prescribed and whether insurance is involved. Here’s how the main routes compare.
| Your situation | What you may pay | The fine print |
|---|---|---|
| Zepbound, with commercial insurance that covers it | As little as $25 for a 1-, 2-, or 3-month fill | Lilly’s Zepbound Savings Card takes off up to $100 a month, up to $1,300 per calendar year.4 |
| Mounjaro, with commercial insurance that covers it | As little as $25 for a 1-, 2-, or 3-month fill | Lilly’s Mounjaro Savings Card takes off up to $150 per month of medication, up to $1,950 per calendar year. The prescription must be for an FDA-approved use, which means type 2 diabetes.5 |
| Brand-name, paying cash | Zepbound KwikPen or vial: $299 (2.5 mg), $399 (5 mg), $449 (7.5 mg to 15 mg) a month. Mounjaro pen: from $499 a month | Sold through LillyDirect. The $449 price on higher Zepbound doses requires refilling within 45 days.6 |
| Compounded tirzepatide through Roen | $329 a month, or $216 a month on a quarterly plan | Prescribed when a Roen provider finds it appropriate and shipped from a partner pharmacy. Not FDA-approved. |
| Medicare, Medicaid, TRICARE, VA, or other government coverage | Lilly savings cards not available | Manufacturer coupons can’t be used with government insurance. Coverage of the drug itself depends on your plan and diagnosis. |
Manufacturer prices and savings-card terms are set by Eli Lilly and can change without notice. Current card terms run through December 31, 2026. Roen prices exclude membership.
Is there a tirzepatide coupon?
- There’s no coupon for “tirzepatide” as such. Each brand has its own savings card from Eli Lilly.
- Both cards need commercial insurance. Neither works with Medicare, Medicaid, or other government coverage.
- The Mounjaro card applies only to prescriptions for an FDA-approved use.
- Manufacturer cards don’t apply to compounded tirzepatide, and coupon-site codes don’t apply to the cards.
What you pay with Roen
- Membership: $39 for the first month, then $135/mo.
- Zepbound or Mounjaro, insurance covers it: as low as $25/mo for the medication.
- Insurance doesn’t cover it: compounded tirzepatide at $329/mo, or $216/mo on a quarterly plan.
Medication is billed separately from membership. Compounded medications are not FDA-approved.
Cheapest tirzepatide: every route, ranked by price
The cheapest tirzepatide is brand-name Zepbound or Mounjaro at $25 a month, but only if your commercial insurance covers it. If it doesn’t, the lowest ongoing price is usually compounded tirzepatide or Lilly’s self-pay price for Zepbound. Here is every legitimate route, lowest price first.
| Route | Monthly price | Who can get it |
|---|---|---|
| Zepbound or Mounjaro with covered insurance and Lilly’s savings card | As little as $25 | People with commercial insurance that covers the brand, prescribed for an FDA-approved use4,5 |
| Zepbound KwikPen through the Medicare GLP-1 Bridge | $50 | Eligible Medicare Part D beneficiaries, July 1, 2026 through December 31, 202711 |
| Compounded tirzepatide through Roen, quarterly plan | $216 | Adults a Roen provider finds it appropriate for. Not FDA-approved |
| Zepbound self-pay, 2.5 mg | $299 | Anyone with a prescription. This is the starting dose, usually for the first four weeks4 |
| Compounded tirzepatide through Roen, monthly plan | $329 | Adults a Roen provider finds it appropriate for. Not FDA-approved |
| Zepbound self-pay, 5 mg | $399 | Anyone with a prescription for the KwikPen or vials4 |
| Zepbound self-pay, 7.5 mg to 15 mg | $449 | Anyone with a prescription who refills within 45 days4 |
| Mounjaro self-pay | From $499 | Anyone with a prescription, through LillyDirect5 |
Prices checked November 2026. Brand prices are set by Eli Lilly and can change. Roen prices are for medication only. Membership is $39 for the first month, then $135 a month.
Cheapest tirzepatide without insurance
Without insurance, you have two real options, and which is cheaper depends on your dose.
- Zepbound vials or KwikPen, self-pay: $299 for the 2.5 mg starting dose, $399 for 5 mg, and $449 for 7.5 mg and higher. It’s FDA-approved, and the price climbs as your dose does.4
- Compounded tirzepatide: $216 a month on Roen’s quarterly plan or $329 month to month, when a provider finds it appropriate. It’s made by a licensed pharmacy and is not FDA-approved.
You’ll need a prescription either way, so count the cost of the visit or membership that comes with it. A price that looks lowest for the medication can cost more overall once visit fees, membership, shipping, and supplies are added.
Cheap tirzepatide to avoid
Some of the lowest prices online are for products you shouldn’t inject. The FDA has warned about all of these.12
- “Research use only” tirzepatide. Vials sold as research chemicals or labeled “not for human consumption” aren’t approved for people to use, and nobody has verified what’s in them.
- Tirzepatide sold without a prescription. A seller that skips the prescription is skipping the medical review too.
- Pens from marketplace listings or social media sellers. They aren’t pharmacies, and the FDA has found counterfeit GLP-1 products in the U.S. supply chain.
- Unclear dosing. The FDA has received reports of dosing errors with compounded GLP-1 medications, often from confusion between milligrams, milliliters, and units. Our tirzepatide units chart explains the conversion.
A legitimate source always involves a licensed prescriber and a state-licensed pharmacy.
How to get the lowest price on tirzepatide
- Check your insurance first. Covered insurance beats every other price. Roen checks coverage for you when you upload your card.
- Match the brand to your diagnosis. Plans cover Mounjaro for type 2 diabetes and Zepbound for weight management or sleep apnea. See Zepbound for sleep apnea.
- Use the right savings card. See the Zepbound cost breakdown and the Mounjaro Savings Card guide.
- If you’re on Medicare, ask about the GLP-1 Bridge. It covers the Zepbound KwikPen for a $50 monthly copay if you qualify.11
- If nothing is covered, compare self-pay Zepbound with compounded tirzepatide at the dose you expect to stay on, not just the starting dose.
- Choose longer fills. A three-month brand fill or a quarterly compounded plan lowers the monthly price.
Looking for a provider? See tirzepatide near me for local and online options, and how to choose an online tirzepatide provider.
Compounded tirzepatide is not a generic. Here’s what it is.
A compounded drug is made by a licensed pharmacy to fill one patient’s prescription. It uses the same active ingredient as the brand, but it doesn’t go through FDA approval.
That means the FDA hasn’t reviewed compounded tirzepatide for safety, effectiveness, or quality before it reaches you.8 It isn’t Zepbound or Mounjaro, and it isn’t a generic version of them.
Through Roen, a licensed provider decides whether compounded tirzepatide is appropriate for you, typically when insurance won’t cover a brand. It’s dispensed by a partner pharmacy and shipped to your door in all 50 states.

| Brand-nameZepbound® or Mounjaro® | Compounded tirzepatide | |
|---|---|---|
| Made by | Eli Lilly | A compounding pharmacy, one prescription at a time |
| FDA-approved | Yes | No. Not reviewed by the FDA for safety, effectiveness, or quality |
| Doses | Six fixed strengths, 2.5 mg to 15 mg | Set by your provider on your prescription |
| Insurance | May be covered, depending on your plan and diagnosis | Generally not covered by insurance |
| Medication cost through Roen | As low as $25/mo with covered insurance and Lilly’s savings card | $329/mo, or $216/mo on a quarterly plan |
| How you get it | Filled through a partner pharmacy | Shipped to your door from a partner pharmacy |
| Where it’s available | All 50 states | All 50 states |
Trial results and side-effect rates on this page come from studies of FDA-approved tirzepatide. Roen is not affiliated with Eli Lilly and Company.

Want to compare tirzepatide with something else?
- Your provider can explain how tirzepatide and semaglutide differ
- Brand-name and compounded routes, with or without insurance
- One membership, whichever medication you’re prescribed
Compare your options:
What members say about their care
Individual experiences vary.
I wanted to understand whether tirzepatide made sense for me, so I came to my provider with plenty of questions. My provider listened to my concerns and explained the options clearly. I appreciated feeling involved in the decision instead of feeling rushed.
What I appreciated most was getting a clear explanation of what treatment with tirzepatide could involve. We discussed my health history, potential side effects, and follow-up check-ins. Having everything explained step by step helped me feel more prepared.
There’s a lot of information about tirzepatide online, and I wanted a conversation focused on my own situation. My provider helped me work through my questions and explained what we would monitor along the way. That personal attention made a difference to my experience.

Tirzepatide is prescribed by licensed providers, not by a form
Your intake is read by a clinician who decides whether tirzepatide is appropriate and which version fits. If it isn’t right for you, you’ll hear that plainly, along with what else to consider.
Tirzepatide FAQs
What are the most common tirzepatide side effects?
The most common tirzepatide side effects are nausea, diarrhea, constipation, vomiting, stomach pain, and indigestion. In the weight-management trials, 25% to 29% of people on tirzepatide reported nausea. In the diabetes trials it was 12% to 18%.
Serious side effects are much rarer and include pancreatitis, gallbladder problems, kidney problems from dehydration, and serious allergic reactions. Tirzepatide carries a boxed warning about thyroid C-cell tumors. See the full side effect table.
What is the usual tirzepatide dosage?
Tirzepatide is taken once a week. The dosage starts at 2.5 mg for four weeks, then goes to 5 mg. After that your provider can raise it 2.5 mg at a time, with at least four weeks on each dose, up to a maximum of 15 mg a week.
For weight management, the maintenance dosage is 5 mg, 10 mg, or 15 mg a week. See the tirzepatide dosage schedule.
Semaglutide vs tirzepatide: which is better for weight loss?
On average, tirzepatide. In the one large head-to-head trial in adults with obesity, people on tirzepatide lost 20.2% of their body weight over 72 weeks and people on semaglutide lost 13.7%.
That doesn’t make tirzepatide the right choice for everyone. Semaglutide has an approved cardiovascular benefit, comes as a pill, and often costs less. Side effects, your medical history, and insurance coverage all matter. See semaglutide vs tirzepatide, or our semaglutide page.
How much does tirzepatide cost?
It depends on the form. Brand-name Zepbound or Mounjaro can cost as little as $25 a month with commercial insurance that covers it and Lilly’s savings card. Paying cash through LillyDirect, Zepbound runs $299 to $449 a month and Mounjaro starts at $499 a month, as of November 2026. Compounded tirzepatide through Roen is $329 a month, or $216 a month on a quarterly plan.
Roen membership is separate: $39 for the first month, then $135 a month. See the full cost breakdown.
How long do tirzepatide side effects last?
They usually peak in the first days after starting or increasing a dose and settle over a few weeks. Because the dose can step up several times, symptoms may return briefly with each increase. If they’re severe or lasting, your provider can slow the schedule or lower your dose.
What is the maximum dose of tirzepatide?
The maximum tirzepatide dosage is 15 mg once a week, for both Zepbound and Mounjaro in adults. Not everyone goes that high. Zepbound’s maintenance dosages for weight management are 5 mg, 10 mg, and 15 mg, and your provider picks one based on your results and how well you tolerate it.
Can you switch from semaglutide to tirzepatide?
Yes, with your provider’s guidance. There’s no official dose conversion between the two medications. Tirzepatide’s prescribing information starts treatment at 2.5 mg a week, and your provider decides how to time the change. Don’t overlap the two or switch on your own.
What is compounded tirzepatide?
It’s tirzepatide prepared by a compounding pharmacy for an individual prescription. It is not FDA-approved, which means the FDA has not reviewed it for safety, effectiveness, or quality, and it is not a generic of Zepbound or Mounjaro. A Roen provider may prescribe it when it’s appropriate for you. See how it compares with the brands.
Is tirzepatide the same as Zepbound and Mounjaro?
Tirzepatide is the active ingredient in both. Zepbound is the brand approved for weight management and sleep apnea in adults with obesity. Mounjaro is the brand approved for type 2 diabetes. They come in the same doses and are both made by Eli Lilly.
How much weight can you lose on tirzepatide?
In the 72-week SURMOUNT-5 trial, adults with obesity lost an average of 20.2% of their body weight on tirzepatide, compared with 13.7% on semaglutide. In SURMOUNT-1, average weight loss ranged from 15.0% to 20.9% depending on dose. These trials studied FDA-approved tirzepatide alongside diet and exercise, and individual results vary.
Is there a generic tirzepatide?
No. There is no FDA-approved generic version of tirzepatide. Zepbound and Mounjaro are the only FDA-approved tirzepatide products. Compounded tirzepatide is a different category and is not FDA-approved.
How do you take tirzepatide?
It’s injected under the skin once a week, on the same day each week, with or without food. The abdomen, thigh, and back of the upper arm are the usual sites. For how the dose builds up, see the tirzepatide dosage schedule.
Do I need a video visit to get tirzepatide through Roen?
No. With a Roen membership, a licensed provider can evaluate you and prescribe asynchronously, with no live appointment to schedule. Visits are included if you’d like one.
What does the Roen membership include?
Membership is $39 for the first month and $135 a month after that. It covers your provider evaluation, visits, insurance coverage checks for Zepbound and Mounjaro, and ongoing support with dosing and side effects. Medication is billed separately.
Which states does Roen serve for tirzepatide?
Roen serves all 50 states. That covers brand-name Zepbound and Mounjaro as well as compounded tirzepatide.
What is the cheapest way to get tirzepatide?
With commercial insurance that covers it, the cheapest tirzepatide is brand-name Zepbound or Mounjaro with Lilly’s savings card, at as little as $25 a month. Eligible Medicare Part D beneficiaries can get the Zepbound KwikPen for a $50 monthly copay through the Medicare GLP-1 Bridge.
Without coverage, the lowest prices are compounded tirzepatide at $216 a month on Roen’s quarterly plan, or Zepbound at Lilly’s self-pay price of $299 to $449 a month depending on dose. See the full ranking.
What is the cheapest tirzepatide without insurance?
Without insurance, compare two options. Zepbound vials or KwikPen cost $299 a month at 2.5 mg, $399 at 5 mg, and $449 at 7.5 mg and higher at Lilly’s self-pay price. Compounded tirzepatide through Roen is $216 a month on a quarterly plan or $329 month to month.
Compare at the dose you expect to stay on, and include visit or membership fees. Compounded medications are not FDA-approved.
Is cheap tirzepatide sold online safe?
It depends on the source. Tirzepatide from a licensed pharmacy with a prescription from a licensed provider is a legitimate route. Products sold without a prescription, or labeled for research use or not for human consumption, are not. The FDA has warned that the quality of these products is unknown and that they may be harmful.
Is compounded tirzepatide cheaper than Zepbound?
Usually, if you’re paying cash. Compounded tirzepatide through Roen is $216 a month on a quarterly plan or $329 month to month. Zepbound’s self-pay price is $299 at the starting dose and $399 to $449 at higher doses.
If your insurance covers Zepbound, the brand is cheaper, at as little as $25 a month with the savings card. Compounded tirzepatide is not FDA-approved and isn’t a generic version of Zepbound.
Read more about tirzepatide
Important safety information
What you should know before taking tirzepatide. This applies to Zepbound and Mounjaro. Assume the same warnings apply to compounded tirzepatide, which has not been evaluated by the FDA.
Boxed warning: risk of thyroid C-cell tumors
Tirzepatide caused thyroid tumors, including thyroid cancer, in studies with rats. It isn’t known whether tirzepatide causes thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Don’t use tirzepatide if you or a family member has ever had MTC, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your provider about any lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath.
Who should not take tirzepatide
- Anyone with a personal or family history of MTC, or with MEN 2.
- Anyone who has had a serious allergic reaction to tirzepatide or any ingredient in the product.
Before you start, tell your provider if you
- Have or have had problems with your pancreas or kidneys.
- Have severe stomach problems, such as slowed stomach emptying (gastroparesis).
- Have type 2 diabetes, a history of diabetic retinopathy, or take insulin or a sulfonylurea.
- Have or have had depression, suicidal thoughts, or other mental health concerns.
- Are scheduled for surgery or a procedure that uses anesthesia or deep sedation.
- Are pregnant, planning to become pregnant, or breastfeeding.
- Use birth control pills. Tirzepatide can make them less effective. Use a non-oral or backup method for 4 weeks after starting and for 4 weeks after each dose increase.
- Use another tirzepatide product or a GLP-1 medicine. They should not be combined.
Possible serious side effects
- Severe stomach problems.
- Kidney problems, including kidney failure, usually related to dehydration.
- Gallbladder problems.
- Inflammation of the pancreas (pancreatitis).
- Serious allergic reactions.
- Low blood sugar, especially when used with insulin or a sulfonylurea.
- Changes in vision in people with type 2 diabetes.
- Depression or thoughts of suicide.
- Food or liquid getting into the lungs during surgery or procedures that use anesthesia.
Most common side effects
Nausea, diarrhea, vomiting, constipation, stomach pain, indigestion, decreased appetite, injection-site reactions, fatigue, allergic reactions, belching, hair loss, and heartburn.
This summary doesn’t include everything about tirzepatide and doesn’t replace a conversation with your provider. Read the full Prescribing Information and Medication Guide for Zepbound or Mounjaro. To report side effects, contact the FDA at 1-800-FDA-1088 or fda.gov/medwatch.
- Aronne LJ, et al. Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). N Engl J Med. 2025;393:26–36.
- Zepbound (tirzepatide) Prescribing Information. Eli Lilly and Company. pi.lilly.com
- Mounjaro (tirzepatide) Prescribing Information. Eli Lilly and Company. pi.lilly.com
- Zepbound savings and insurance options. Eli Lilly and Company. zepbound.lilly.com/savings
- Mounjaro savings and support. Eli Lilly and Company. mounjaro.lilly.com/savings-resources
- Zepbound through LillyDirect. Eli Lilly and Company. lilly.com/lillydirect/zepbound
- Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387:205–216.
- Compounding and the FDA: questions and answers. U.S. Food and Drug Administration. fda.gov
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384:989–1002.
- Wegovy (semaglutide) Prescribing Information. Novo Nordisk. novo-pi.com
- Medicare GLP-1 Bridge. Centers for Medicare & Medicaid Services. cms.gov
- FDA’s concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration. fda.gov
Page last updated November 17, 2026.
See which form of tirzepatide fits you
Answer a few questions and a licensed provider will review your options. Your first month of membership is $39.
Get StartedZepbound®, Mounjaro®, KwikPen®, and LillyDirect® are registered trademarks of Eli Lilly and Company. Ozempic®, Wegovy®, and NovoCare® are registered trademarks of Novo Nordisk A/S. Roen is not affiliated with or endorsed by these companies. Prescriptions are issued only after a licensed provider determines that treatment is appropriate. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. This page is for general information and is not medical advice.



